Patent ID: 6436990
Filing Date: 2002-08-20
Classification: A61K,A61P

Abstract:
A pharmaceutical composition useful for treatment of inflammation in humans comprising a therapeutically effective amount of a compound of the formula:wherein R is selected from the group consisting of (CH2)mO(CH2)n; (CH2)m(OC2H4)pO(CH2)n; (CH2)m(CHOH)r(CHOH)s, or the (R) or (S) enantiomer or a mixture thereof; and CHCORâ€²; wherein m is an integer from 2 to 4, n and p are integers from 1 to 4 and r and s are integers from 1 to 2, and Râ€² is selected from the group consisting of C1 to C6 alkyl, (CH2)mO(CH2)n, CH2 (OC2H4)pO(CH2)n, and CH2 (OC2H4)p.